Results 191 to 200 of about 73,057 (319)
Abstract A 5‐year‐old male neutered standard poodle, presented with recurrent gingival margin haemorrhage and associated prolongations in prothrombin time and activated partial thromboplastin time, with repeatable demonstration of clinical (bleeding) and laboratory (prothrombin time, activated partial thromboplastin time) resolution with, and relapse ...
Jenny Reeve, Aiden Pang
wiley +1 more source
Characterization of a PNLIP variant identified in Amish pediatric patients with congenital pancreatic lipase deficiency. [PDF]
Curry GE +10 more
europepmc +1 more source
Structure-activity relationship of dietary flavonoids on pancreatic lipase. [PDF]
Li MM +5 more
europepmc +1 more source
Abstract Aims Survodutide is an investigational glucagon receptor/glucagon‐like peptide‐1 receptor dual agonist that has shown promise for treating obesity and its complications in Phase 2 trials. Two double‐blind, randomized, global Phase 3 trials are designed to assess the efficacy and safety of survodutide for treatment of obesity—SYNCHRONIZE™‐1 in ...
Sean Wharton +9 more
wiley +1 more source
Progression of lipase activity and pancreatic lipase immunoreactivity in clinically healthy cats and cats with diet-responsive enteropathy. [PDF]
Moscoso Uribe F +6 more
europepmc +1 more source
Secondary Metabolites from the Coral-Derived Fungus Aspergillus austwickii SCSIO41227 with Pancreatic Lipase and Neuraminidase Inhibitory Activities. [PDF]
Chen Y +5 more
europepmc +1 more source
A metabolic comparison of GIPR agonism versus GIPR antagonism in male mice
Abstract Aims Targeting the glucose dependent insulinotropic polypeptide receptor (GIPR) is of growing interest for treating type 2 diabetes and obesity, though the optimal approach remains unclear. Both GIPR agonism and antagonism, respectively, incorporated into drugs like tirzepatide and maridebart cafraglutide, have paradoxically both shown ...
Iona Davies +11 more
wiley +1 more source
Exploring the Novel Pancreatic Lipase-Inhibitory Peptides in <i>Chlorella pyrenoidosa</i>: Preparation, Purification, Identification, and Molecular Docking. [PDF]
Wang D +6 more
europepmc +1 more source

